News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,042 Results
Type
Article (17085)
Company Profile (33)
Press Release (250924)
Multimedia
Podcasts (17)
Webinars (5)
Section
Business (81422)
Career Advice (579)
Deals (14375)
Drug Delivery (25)
Drug Development (34187)
Employer Resources (40)
FDA (6166)
Job Trends (6253)
News (135009)
Policy (10261)
Tag
Academia (748)
Accelerated approval (3)
Adcomms (5)
Allergies (43)
Alliances (14497)
ALS (50)
Alzheimer's disease (524)
Antibody-drug conjugate (ADC) (56)
Approvals (6245)
Artificial intelligence (151)
Autoimmune disease (22)
Automation (10)
Bankruptcy (116)
Best Places to Work (4790)
BIOSECURE Act (2)
Biosimilars (56)
Biotechnology (24)
Bladder cancer (67)
Brain cancer (20)
Breast cancer (229)
Cancer (1584)
Cardiovascular disease (108)
Career advice (474)
Career pathing (6)
CAR-T (74)
CDC (3)
Cell therapy (232)
Cervical cancer (13)
Clinical research (29936)
Collaboration (488)
Company closure (1)
Compensation (320)
Complete response letters (1)
COVID-19 (917)
CRISPR (30)
C-suite (128)
Cystic fibrosis (48)
Data (1795)
Decentralized trials (1)
Denatured (4)
Depression (25)
Diabetes (153)
Diagnostics (2232)
Digital health (13)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (62)
Drug pricing (43)
Drug shortages (9)
Duchenne muscular dystrophy (59)
Earnings (49428)
Editorial (11)
Employer branding (7)
Employer resources (35)
Events (43751)
Executive appointments (431)
FDA (7054)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (476)
Gene editing (58)
Generative AI (9)
Gene therapy (176)
GLP-1 (398)
Government (1334)
Grass and pollen (4)
Guidances (160)
Healthcare (6625)
Huntington's disease (9)
IgA nephropathy (24)
Immunology and inflammation (63)
Immuno-oncology (4)
Indications (20)
Infectious disease (1002)
Inflammatory bowel disease (60)
Inflation Reduction Act (6)
Influenza (34)
Intellectual property (58)
Interviews (112)
IPO (8005)
IRA (14)
Job creations (1759)
Job search strategy (409)
Kidney cancer (7)
Labor market (21)
Layoffs (166)
Leadership (2)
Legal (2179)
Liver cancer (37)
Lung cancer (241)
Lymphoma (112)
Machine learning (3)
Management (12)
Manufacturing (158)
MASH (54)
Medical device (4757)
Medtech (4757)
Mergers & acquisitions (6768)
Metabolic disorders (394)
Multiple sclerosis (55)
NASH (10)
Neurodegenerative disease (53)
Neuropsychiatric disorders (13)
Neuroscience (854)
NextGen: Class of 2025 (2372)
Non-profit (1583)
Now hiring (10)
Obesity (191)
Opinion (62)
Ovarian cancer (52)
Pain (44)
Pancreatic cancer (54)
Parkinson's disease (98)
Partnered (9)
Patents (115)
Patient recruitment (68)
Peanut (18)
People (16090)
Pharmaceutical (9)
Pharmacy benefit managers (4)
Phase I (8228)
Phase II (13160)
Phase III (11155)
Pipeline (1159)
Policy (46)
Postmarket research (1070)
Preclinical (2767)
Press Release (44)
Prostate cancer (81)
Psychedelics (9)
Radiopharmaceuticals (88)
Rare diseases (201)
Real estate (2119)
Recruiting (14)
Regulatory (7735)
Reports (20)
Research institute (679)
Resumes & cover letters (117)
Rett syndrome (9)
RNA editing (4)
RSV (24)
Schizophrenia (40)
Series A (72)
Series B (49)
Service/supplier (5)
Sickle cell disease (25)
Special edition (8)
Spinal muscular atrophy (64)
Sponsored (12)
Startups (1231)
Stomach cancer (3)
Supply chain (36)
Tariffs (17)
The Weekly (13)
Vaccines (318)
Venture capital (15)
Weight loss (126)
Women's health (16)
Worklife (3)
Date
Last 7 days (173)
Last 30 days (861)
Last 365 days (16863)
2025 (9267)
2024 (15104)
2023 (15017)
2022 (18874)
2021 (20133)
2020 (17970)
2019 (15532)
2018 (11807)
2017 (10742)
2016 (11550)
2015 (44338)
2014 (19407)
2013 (5929)
2012 (6496)
2011 (7322)
2010 (6287)
Location
Africa (367)
Alabama (21)
Alaska (3)
Arizona (62)
Arkansas (3)
Asia (16327)
Australia (2642)
California (3919)
Canada (1133)
China (303)
Colorado (163)
Connecticut (210)
Delaware (141)
Europe (39609)
Florida (479)
Georgia (103)
Hawaii (1)
Idaho (19)
Illinois (342)
India (13)
Indiana (202)
Iowa (7)
Japan (147)
Kansas (35)
Kentucky (11)
Louisiana (10)
Maine (30)
Maryland (457)
Massachusetts (2986)
Michigan (148)
Minnesota (184)
Mississippi (2)
Missouri (57)
Montana (11)
Nebraska (5)
Nevada (47)
New Hampshire (25)
New Jersey (1237)
New Mexico (5)
New York (1020)
North Carolina (468)
North Dakota (3)
Northern California (1711)
Ohio (98)
Oklahoma (5)
Oregon (14)
Pennsylvania (704)
Puerto Rico (2)
Rhode Island (5)
South America (469)
South Carolina (9)
Southern California (1429)
Tennessee (80)
Texas (596)
United States (14137)
Utah (116)
Virginia (90)
Washington D.C. (29)
Washington State (334)
West Virginia (3)
Wisconsin (58)
268,042 Results for "15".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LakeShore Biopharma Announces US$15 Million Private Placement Financing
July 9, 2025
·
3 min read
Press Releases
Niagen Bioscience to Participate at the Roth 15th Annual London Conference
June 23, 2025
·
2 min read
Press Releases
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
July 9, 2025
·
4 min read
Press Releases
Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock
June 25, 2025
·
7 min read
Press Releases
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing
June 24, 2025
·
6 min read
Press Releases
AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025
July 7, 2025
·
1 min read
Collaboration
Argenx Makes $1.5B+ Play for UNP’s Macrocyclic Peptides Aimed at ‘Undruggable’ Targets
Macrocyclic peptides are designed to engage complex targets like biologics but pass through cell membranes like small molecule drugs.
July 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET
July 10, 2025
·
5 min read
Press Releases
Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates
May 14, 2025
·
3 min read
Press Releases
Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval
July 8, 2025
·
6 min read
1 of 26,805
Next
